KaramjeetSinghSandhuMD

Hematology • Duarte, CA

Hematologic Oncology, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology

Assistant Professor

Join to view full profile

Dr. Sandhu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sandhu's full profile

Already have an account?

Office
1500 Duarte Rd
Dept of Hematology Hematopoietic Cell Transplantation
Duarte, CA 91010
Phone+1 626-256-4673

Fax+1 626-301-8116

Education & Training

University of MinnesotaFellowship, Hematology and Medical Oncology, 2012 - 2015
Hennepin HealthcareResidency, Internal Medicine, 2009 - 2012
Tver State Medical AcademyClass of 2000

Certifications & Licensure

CA State Medical License 2014 - 2026
MN State Medical License 2014 - 2016

Clinical Trials

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant Start of enrollment: 2021 Apr 30
Recruiting
Phase 1
Roles: Principal Investigator, Contact
Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML Start of enrollment: 2021 Nov 24
Terminated
Phase 3
Roles: Contact
Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation Start of enrollment: 2023 Sep 18
Recruiting
Phase 2
Roles: Contact
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia Start of enrollment: 2023 Dec 07
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease Start of enrollment: 2024 Jun 30
Suspended
Early Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leuke...
Ibrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, Caner Saygin, Marjorie Robbins
Haematologica. 2024-11-07
Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings.
Salman Otoukesh, Dongyun Yang, Sally Mokhtari, Hoda Pourhassan, Vaibhav Agrawal
Bone Marrow Transplantation. 2024-11-01
A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT.
Zachariah DeFilipp, Haesook T Kim, Guang-Shing Cheng, Betty K Hamilton, Saurabh Chhabra
Blood Advances. 2024-10-04

Abstracts/Posters

The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
Karamjeet S. Sandhu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplan...
Karamjeet S. Sandhu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

City of Hope Doctors Present New Research on Cancer ImmunotherapiesNovember 4th, 2021
Initial Patient Dosed in Phase 2a Clinical Trial Evaluating First-in-Class Human Milk-Based Therapy in Patients Undergoing Stem Cell Transplantation for Blood CancersNovember 15th, 2023